Enter assignee name

EPO Patents = 3

Trademarks = 1

Forward Citations = 26

Loading Chart...

9 inventors (with patents filed for the assignee):

Kenneth R Chien (8 out of 30 patents)

Jonathan Clarke (6 out of 7 patents)

Chuen Yan Leung (6 out of 6 patents)

4. Miia Lehtinen (2 out of 2 patents)

5. Kylie Foo (2 out of 2 patents)

6. Jiejia Xu (2 out of 2 patents)

7. Federica Santoro (2 out of 2 patents)

8. Makoto Sahara (2 out of 2 patents)

9. Xiaojun Lance Lian (2 out of 11 patents)

8 patents: Sort by Forward Citations

1. 12404488 - Use of neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells (2025-09-02),

2. 11725244 - Genetic markers for engraftment of human cardiac ventricular progenitor cells (2023-08-15),

3. 11401508 - Methods for isolating human cardiac ventricular progenitor cells (2022-08-02),

4. 11186820 - Use of Neuropilin-1 (NRP1) as a cell surface marker for isolating human cardiac ventricular progenitor cells (2021-11-30),

5. 10612094 - Genetic markers for engraftment of human cardiac ventricular progenitor cells (2020-04-07),

6. 10597637 - Use of jagged 1/frizzled 4 as a cell surface marker for isolating human cardiac ventricular progenitor cells (2020-03-24),

7. 10596200 - Use of LIFR or FGFR3 as a cell surface marker for isolating human cardiac ventricular progenitor cells (2020-03-24),

8. 10508263 - Methods for isolating human cardiac ventricular progenitor cells (2019-12-17),

Procella Therapeutics Ab is a biotechnology company focused on developing innovative gene therapy and cell therapy treatments for rare and genetic diseases. Their mission is to improve the lives of patients by providing personalized and targeted therapies that address the underlying causes of their conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#1 in Tullinge

#686 in Sweden

Tullinge, Sweden

Procella Therapeutics Ab